Sara Glassley
Nurse Practitioner · Fort Wayne, INNPI 1750722773
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $854 and has fallen 61.8% since, to $327 in 2025.
Across 103 payments — averaging $24.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$325
- E.r. Squibb & Sons, L.L.C.$296
- AbbVie$280
- Alkermes, Inc.$265
- Supernus Pharmaceuticals, Inc.$263
- Sunovion Pharmaceuticals Inc.$250
- plus $877 from 13 others
What the payments were for
- Food & beverage$2,556100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $325 |
| E.r. Squibb & Sons, L.L.C. | 12 | $296 |
| AbbVie | 6 | $280 |
| Alkermes, Inc. | 6 | $265 |
| Supernus Pharmaceuticals, Inc. | 15 | $263 |
| Sunovion Pharmaceuticals Inc. | 16 | $250 |
| Axsome Therapeutics, Inc. | 7 | $214 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $182 |
| Neurocrine Biosciences, Inc. | 6 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Lundbeck LLC | 5 | $75 |
| Bausch Health US, LLC | 3 | $47 |
| Corium, LLC | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Eisai Inc. | 2 | $24 |
| Adlon Therapeutics L.p. | 2 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,556 in reported general payments places this provider in the 85th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $1,363 |
| Duloxetine Hcl | 46 | $747 |
| Trazodone Hcl | 52 | $461 |
| Mirtazapine | 16 | $401 |
| Bupropion XlBupropion Hcl | 16 | $385 |
| Bupropion Hcl SrBupropion Hcl | 27 | $377 |
| Lamotrigine | 28 | $306 |
| Gabapentin | 22 | $242 |
| Buspirone Hcl | 14 | $239 |
| Escitalopram Oxalate | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fort Wayne
- Sean GoddardFort Wayne$180K
- Kristine TaylorFort Wayne$69K
- Mary BullisFort Wayne$27K
- Nathan MinerFort Wayne$21K
- Joel NagelFort Wayne$20K
- Gabriela NorthFort Wayne$18K
- Karen LothamerFort Wayne$12K
- Pamela ShodaFort Wayne$11K
- Sara CoburnFort Wayne$9K
- Marlise FletterFort Wayne$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.